Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDA | P32320 | 8/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.35 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12194530 | 1.00 | CDA (0.37) | CDAPDE4DPDE3ASLC29A1 | |
| SCHEMBL15070549 | 0.84 | CDA (0.49) | CDAPDE4DPDE3ASLC29A1 | |
| SCHEMBL16643735 | 0.84 | CDA (0.49) | CDAPDE4DPDE3ASLC29A1 | |
| SCHEMBL19866473 | 0.79 | — | — | |
| SCHEMBL17742251 | 0.76 | — | — | |
| SCHEMBL17737009 | 0.72 | — | — | |
| SCHEMBL19535784 | 0.71 | PDE4D (0.48) | CDAPDE4DPDE3ASLC29A1 | |
| SCHEMBL19536892 | 0.71 | PDE4D (0.48) | CDAPDE4DPDE3ASLC29A1 | |
| SCHEMBL19535786 | 0.71 | PDE4D (0.48) | CDAPDE4DPDE3ASLC29A1 | |
| SCHEMBL1375433 | 0.70 | LMNA (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110243886-A1 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS | SURLERAUX DOMINIQUE | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110243886-A1 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS | HAVCR2, PYGL, EIF2AK2 | CDA 289/4885PDE4D 1273/4885PDE3A 704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.